FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

35542711000001109: Renocontin 30mg modified-release tablets (Glenmark Pharmaceuticals Europe Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 13-Jun 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
107161801000001116 Renocontin 30mg modified-release tablets (Glenmark Pharmaceuticals Europe Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
107161901000001110 Renocontin 30mg modified-release tablets (Glenmark Pharmaceuticals Europe Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Renocontin 30mg modified-release tablets (Glenmark Pharmaceuticals Europe Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 2 (CD) true Inferred relationship Existential restriction modifier
Renocontin 30mg modified-release tablets (Glenmark Pharmaceuticals Europe Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Renocontin 30mg modified-release tablets (Glenmark Pharmaceuticals Europe Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Renocontin 30mg modified-release tablets (Glenmark Pharmaceuticals Europe Ltd) Is a Oxycodone hydrochloride 30mg m/r tablet false Inferred relationship Existential restriction modifier
Renocontin 30mg modified-release tablets (Glenmark Pharmaceuticals Europe Ltd) Has active ingredient Oxycodone hydrochloride true Inferred relationship Existential restriction modifier
Renocontin 30mg modified-release tablets (Glenmark Pharmaceuticals Europe Ltd) Has manufactured dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Renocontin 30mg modified-release tablets (Glenmark Pharmaceuticals Europe Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Renocontin 30mg modified-release tablets (Glenmark Pharmaceuticals Europe Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Renocontin 30mg modified-release tablets (Glenmark Pharmaceuticals Europe Ltd) Has specific active ingredient Oxycodone hydrochloride true Inferred relationship Existential restriction modifier
Renocontin 30mg modified-release tablets (Glenmark Pharmaceuticals Europe Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Renocontin 30mg modified-release tablets (Glenmark Pharmaceuticals Europe Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Renocontin 30mg modified-release tablets (Glenmark Pharmaceuticals Europe Ltd) Has excipient Stearyl alcohol false Inferred relationship Existential restriction modifier
Renocontin 30mg modified-release tablets (Glenmark Pharmaceuticals Europe Ltd) Is a Renocontin true Inferred relationship Existential restriction modifier
Renocontin 30mg modified-release tablets (Glenmark Pharmaceuticals Europe Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Renocontin 30mg modified-release tablets (Glenmark Pharmaceuticals Europe Ltd) Is a Oxycodone 30mg modified-release tablets false Inferred relationship Existential restriction modifier
Renocontin 30mg modified-release tablets (Glenmark Pharmaceuticals Europe Ltd) Is a Oxycodone 30mg modified-release tablets true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Renocontin 30mg modified-release tablets (Glenmark Pharmaceuticals Europe Ltd) 56 tablet 4 x 14 tablets Has AMP True Renocontin 30mg modified-release tablets (Glenmark Pharmaceuticals Europe Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start